Public health breakthrough in Virginia: state’s first ultra-low-dose x-ray imager, ‘EOS’, which reduces radiation by up to 90% compared to conventional x-rays, is installed at Spinal Surgery Associates
“EOS is remarkable technology because it drastically cuts x-ray radiation exposure for adults and kids while making very precise images for indisputable clinical interpretation.”
William Sukovich, M.D., Spinal Surgery Associates, PLC
CHARLOTTESVILLE, Va.–(BUSINESS WIRE)– Biospace med, an emerging medical technology company based in Cambridge, Mass., and Paris, announced today that Charlottesville, Va.-based Spinal Surgery Associates is the first healthcare facility in the state of Virginia to install the Company’s FDA-cleared ‘EOS’ x-ray imager—the world’s first ultra-low-dose x-ray technology.
EOS can capture head-to-toe images of patients in a standing, weight-bearing position with a dramatic reduction in radiation dose—up to 10 times less than a conventional x-ray and up to 1000 times less than a CT (Computed Tomography) scan. Additionally, EOS images are designed to provide incredible detail and enable physicians to better diagnose and plan an effective course of treatment.
“High-quality spine-imaging is critical to my surgery-planning yet very difficult to obtain,” said William Sukovich, M.D., a spinal surgery specialist and founder of Spinal Surgery Associates. “Until now, I have not been able to obtain an x-ray image quality that is suitable for my needs. But when I saw the superb image quality from EOS output in spine exams—and at such reduced irradiation compared to conventional x-ray imaging—my decision to acquire EOS was immediate. EOS is exactly what a single-surgeon spine practice like mine needs.”
“We are tremendously pleased to announce the first installation of our ultra-low-dose EOS x-ray imager in one of the leading spine centers in the state of Virginia,” said Marie Meynadier, Ph.D., chief executive officer of Biospace med. “EOS represents an entirely new paradigm for the safe and effective imaging of patients, and we are looking forward to rolling out this revolutionary technology throughout the state of Virginia and across the United States.”
About Biospace med
Biospace med was founded on a unique partnership between Nobel Prize-winning physicist Georges Charpak, Ph.D., and a team of biomedical engineers, orthopedic surgeons and radiologists who have developed a complete orthopedic imaging solution. The Company’s lead product, EOS ultra-low-dose 2D/3D x-ray imager, allows full-body imaging of patients in a weight-bearing position that enables global assessment of balance and posture. EOS is a total solution in orthopedic imaging now available in the U.S. since receiving FDA 510(k) clearance. The Company has corporate headquarters in Cambridge, Mass., and Paris, as well as an office in Montreal, and is targeting a $2 billion orthopedic imaging marketplace. The company’s U.S. headquarters is located at 185 Alewife Brook Parkway, #410, Cambridge, Mass., (toll free: +1-866-933-5301. Learn more at www.biospacemed.com.